Evonik (GB:0QDS)
LSE:0QDS
Holding GB:0QDS?
Track your performance easily

Evonik (0QDS) Technical Analysis

4 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Evonik’s (0QDS) Moving Averages Convergence Divergence (MACD) indicator is 0.31, suggesting Evonik is a Sell.
Evonik’s (0QDS) 20-Day exponential moving average is 19.78, while Evonik’s (0QDS) share price is €20.522, making it a Buy.
Evonik’s (0QDS) 50-Day exponential moving average is 19.36, while Evonik’s (0QDS) share price is €20.522, making it a Buy.

Evonik (0QDS) Pivot Points

Sep 20, 2024, 12:39 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.45
19.75
20.07
20.37
20.69
20.99
21.31
Fibonacci
19.75
19.98
20.13
20.37
20.60
20.75
20.99
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Evonik (0QDS) Moving Averages

Sep 20, 2024, 12:39 AM
Period
Simple
Exponential
MA5
20.12Buy
20.20Buy
MA10
19.94Buy
20.02Buy
MA20
19.83Buy
19.78Buy
MA50
19.18Buy
19.36Buy
MA100
19.05Buy
18.90Buy
MA200
17.90Buy
18.00Buy
Evonik’s (0QDS) 10-Day exponential moving average is 20.02, while Evonik’s (0QDS) share price is €20.522, making it a Buy.
Evonik’s (0QDS) 100-Day exponential moving average is 18.90, while Evonik’s (0QDS) share price is €20.522, making it a Buy.
Evonik’s (0QDS) stock price is €20.522 and Evonik’s (0QDS) 50-day simple moving average is 19.18, creating a Buy signal.
Evonik’s (0QDS) stock price is €20.522 and Evonik’s (0QDS) 100-day simple moving average is 19.05, creating a Buy signal.
Evonik’s (0QDS) stock price is €20.522 and Evonik’s (0QDS) 200-day simple moving average is 17.90, creating a Buy signal.

Evonik (0QDS) Technical Indicators

Sep 20, 2024, 12:39 AM
Name
Value
Implied Action
RSI (14)
72.62
Sell
STOCH (9,6)
78.56
Neutral
STOCHRSI (14)
76.89
Neutral
MACD (12,26)
0.31
Sell
ADX (14)
28.82
Neutral
Williams %R
-11.67
Sell
CCI (14)
216.98
Sell
ATR (14)
0.32
-
Ultimate Oscillator
55.26
Neutral
ROC
3.01
Buy
Evonik’s (0QDS) Relative Strength Index (RSI) is 72.62, creating a Sell signal.
Evonik’s (0QDS) Trend Strength Indicator (ADX) is 28.82, creating a Neutral signal.
Evonik’s (0QDS) Commodity Channel Index (CCI) is 216.98, creating a Sell signal.
Evonik’s (0QDS) Price Rate of Change (ROC) is 3.01, creating a Buy signal.

FAQ

Is 0QDS a Buy, Hold, or Sell?
Based on 0QDS’s technical indicators, 0QDS is a Buy.
    What is 0QDS’s RSI (14)?
    0QDS’s RSI (14) is 72.62, which suggests 0QDS is a Sell.
      What is 0QDS’s MACD?
      0QDS’s MACD is 0.31, which suggests 0QDS is a Sell.
        What is 0QDS’s 5-day moving average?
        0QDS’s 5-day moving average is 20.12, which suggests 0QDS is a Buy.
          What is 0QDS’s 20-day moving average?
          0QDS 20-day moving average is 19.83, which suggests 0QDS is a Buy.
            What is 0QDS’s 50-day moving average?
            0QDS’s 50-day moving average is 19.18, which suggests 0QDS is a Buy.
              What is 0QDS’s 200-day moving average?
              0QDS’s 200-day moving average is 17.90, which suggests 0QDS is a Buy.
                What is 0QDS’s Williams % R (14)?
                0QDS’s Williams % R (14) is -11.67, which suggests 0QDS is a Sell.
                  What is 0QDS’s CCI (14)?
                  0QDS’s CCI (14) is 216.98, which suggests 0QDS is a Sell.
                    What is the share price of Evonik?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis